Noticias de GH_US
Noticias del mercado
Últimas noticias sobre GH_US — 417 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
TwinStrand Biosciences and University of Washington secured a final court judgment awarding more than $245.2 million in damages and royalties from.
SEATTLE, August 24, 2026--TwinStrand Biosciences (TwinStrand), the pioneer in Duplex Sequencing® technology, today announced that the U.S. District Court for the District of Delaware entered final judgment on Aug. 21, 2026, in favor of TwinStrand and the University of Washington (UW) in their patent infringement suit against Guardant Health, Inc. (Nasdaq: GH). The final judgment preserves a November 2023 jury verdict finding that Guardant Health willfully infringed two core patents underlying Tw
A judge has boosted what Guardant Health Inc. owes in a case in which it was found to have infringed two TwinStrand Biosciences Inc. patents covering methods of lowering the error rate in DNA sequencing, bringing the total to $245 million.
Página 11 de 21